Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects
Abstract CYP2C9, one of the most abundant hepatic cytochrome P450 enzymes, is involved in metabolism of 15–20% of clinically important drugs (warfarin, sulfonylureas, phenytoin, non-steroid anti-inflammatory drugs). To avoid adverse events and/or impaired drug-response, CYP2C9 pharmacogenetic testin...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b6e9c3ef1c064e07b6526c64bf166e4e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|